Real-world cross-sectional study evaluating patient characteristics, disease burden, and treatment approaches in people with obesity disease in Japan
People with high-degree obesity disease experienced greater disease burden. Diet and exercise are common for weight management, while behavioral therapy is less frequently implemented. These findings highlight the challenges and unmet medical needs in treating obesity in Japan and could inform better treatment strategies in Japan and globally among the Asian population.
Authors
- Andrea Leith (ORCID: https://orcid.org/0000-0002-1147-5306)
- Takuto Kojima
- Tomotaka Shingaki (ORCID: https://orcid.org/0000-0003-1568-9763)
- Swarna Khare (ORCID: https://orcid.org/0000-0001-6991-0254)
- Victoria Higgins (ORCID: https://orcid.org/0000-0002-3901-7390)
- Swathi Pathadka (ORCID: https://orcid.org/0000-0002-1793-1800)
- Tomohiro Tanaka (ORCID: https://orcid.org/0000-0002-6212-4274)
Institutions
- Eli Lilly (United States) (US)
- Nagoya City University (JP)
- Adelphi Group (United Kingdom) (GB)
- Eli Lilly (Japan) (JP)
- Eli Lilly (India) (IN)
Publication Details
- Journal
- Current Medical Research and Opinion
- Published
- 2025-04-03
- DOI
- https://doi.org/10.1080/03007995.2025.2486167
- Citations
- 1
- Primary Topic
- Pharmacology and Obesity Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.39